| Desoto Family Medical Center | |
|
75 Physician Lane Southaven MS 38671 | |
| (662) 393-7722 | |
| (662) 393-7756 |
| Full Name | Desoto Family Medical Center |
|---|---|
| Speciality | Family Medicine |
| Location | 75 Physician Lane, Southaven, Mississippi |
| Authorized Official Name and Position | Angel Burnette (FINANCIAL SERVICES MANAGER) |
| Authorized Official Contact | 6622806233 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Desoto Family Medical Center 75 Physician Lane Southaven MS 38671 Ph: (662) 393-7722 | Desoto Family Medical Center 75 Physician Lane Southaven MS 38671 Ph: (662) 393-7722 |
| NPI Number | 1528150398 |
|---|---|
| Provider Enumeration Date | 09/29/2006 |
| Last Update Date | 10/10/2008 |
| Medicare PECOS PAC ID | 2567470412 |
|---|---|
| Medicare Enrollment ID | O20060404000200 |
News Archive
Global medical device designer and manufacturer Devon Medical Products today announced substantial additions to its Negative Pressure Wound Therapy (NPWT) wound care product line after receiving Food & Drug Administration 510(k) clearance to market its extriCARE 3600 NPWT pump and foam dressing kit.
The St. Laurent Institute, a non-profit medical research institute focused on the systems biology of disease, today announced in a study published in the July edition of Genome Biology, that genetic matter, previously ignored by the scientific community, may play an important role in cancer.
Brigham surgical teams have performed face transplants for people who have suffered from severe facial injuries.
Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB) under investigation for the treatment of hypertension. Discovered by Takeda, azilsartan medoxomil is designed to lower blood pressure by blocking the action of a vasopressor hormone, angiotensin II.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528150398 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Troy Dale Morris |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1891792883 PECOS PAC ID: 1557379401 Enrollment ID: I20091228000162 |
News Archive
Global medical device designer and manufacturer Devon Medical Products today announced substantial additions to its Negative Pressure Wound Therapy (NPWT) wound care product line after receiving Food & Drug Administration 510(k) clearance to market its extriCARE 3600 NPWT pump and foam dressing kit.
The St. Laurent Institute, a non-profit medical research institute focused on the systems biology of disease, today announced in a study published in the July edition of Genome Biology, that genetic matter, previously ignored by the scientific community, may play an important role in cancer.
Brigham surgical teams have performed face transplants for people who have suffered from severe facial injuries.
Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB) under investigation for the treatment of hypertension. Discovered by Takeda, azilsartan medoxomil is designed to lower blood pressure by blocking the action of a vasopressor hormone, angiotensin II.
› Verified 2 days ago
| Provider Name | Antronette L Mckenzie |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1336146315 PECOS PAC ID: 8022066323 Enrollment ID: I20100125000041 |
News Archive
Global medical device designer and manufacturer Devon Medical Products today announced substantial additions to its Negative Pressure Wound Therapy (NPWT) wound care product line after receiving Food & Drug Administration 510(k) clearance to market its extriCARE 3600 NPWT pump and foam dressing kit.
The St. Laurent Institute, a non-profit medical research institute focused on the systems biology of disease, today announced in a study published in the July edition of Genome Biology, that genetic matter, previously ignored by the scientific community, may play an important role in cancer.
Brigham surgical teams have performed face transplants for people who have suffered from severe facial injuries.
Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB) under investigation for the treatment of hypertension. Discovered by Takeda, azilsartan medoxomil is designed to lower blood pressure by blocking the action of a vasopressor hormone, angiotensin II.
› Verified 2 days ago
| Provider Name | Amy E Bailey |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1003161373 PECOS PAC ID: 2365664604 Enrollment ID: I20141120002206 |
News Archive
Global medical device designer and manufacturer Devon Medical Products today announced substantial additions to its Negative Pressure Wound Therapy (NPWT) wound care product line after receiving Food & Drug Administration 510(k) clearance to market its extriCARE 3600 NPWT pump and foam dressing kit.
The St. Laurent Institute, a non-profit medical research institute focused on the systems biology of disease, today announced in a study published in the July edition of Genome Biology, that genetic matter, previously ignored by the scientific community, may play an important role in cancer.
Brigham surgical teams have performed face transplants for people who have suffered from severe facial injuries.
Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB) under investigation for the treatment of hypertension. Discovered by Takeda, azilsartan medoxomil is designed to lower blood pressure by blocking the action of a vasopressor hormone, angiotensin II.
› Verified 2 days ago
News Archive
Global medical device designer and manufacturer Devon Medical Products today announced substantial additions to its Negative Pressure Wound Therapy (NPWT) wound care product line after receiving Food & Drug Administration 510(k) clearance to market its extriCARE 3600 NPWT pump and foam dressing kit.
The St. Laurent Institute, a non-profit medical research institute focused on the systems biology of disease, today announced in a study published in the July edition of Genome Biology, that genetic matter, previously ignored by the scientific community, may play an important role in cancer.
Brigham surgical teams have performed face transplants for people who have suffered from severe facial injuries.
Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB) under investigation for the treatment of hypertension. Discovered by Takeda, azilsartan medoxomil is designed to lower blood pressure by blocking the action of a vasopressor hormone, angiotensin II.
› Verified 2 days ago
Carnahan Clinic Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7900 Airways Blvd Bldg A Ste 6, Southaven, MS 38671 Phone: 662-536-4646 Fax: 662-536-4443 | |
Holistic Family Health By Hodge Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5699 Getwell Rd Ste 3, Southaven, MS 38672 Phone: 662-420-3264 | |
Narayanan Pediatric Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3964 Goodman, Ste 133, Southaven, MS 38672 Phone: 662-895-9498 Fax: 662-890-4547 | |
Family Medical Clinic Of North Ms Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3451 Goodman Rd, Ste 115, Southaven, MS 38672 Phone: 662-890-5555 Fax: 662-890-8899 | |
Dr Kiandokht Partovi Pc Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5410 Windy Ridge Dr, Southaven, MS 38671 Phone: 662-449-4308 | |
Baptist Memorial Hospital-desoto, Inc, Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 7601 Southcrest Pkwy, Southaven, MS 38671 Phone: 662-349-4000 | |
Midsouth Medicine Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2149 Stateline Rd W, Southaven, MS 38671 Phone: 662-342-1112 Fax: 662-342-1116 |